Istituto Rudy Lanza - Alta formazione in Naturopatia

Istituto Rudy Lanza - Catalogo bibliografico delle tesi

Gli abstracts delle tesi in Naturopatia elaborate presso l'Istituto Rudy Lanza

Approccio naturopatico al trattamento del carcinoma della vescica e alla gestione degli effetti collaterali della terapia convenzionale

Autore/autrice
Cazzavillan Stefania
Anno
2006
Numero
1043

Abstract

Negli ultimi 3 anni si sono rivolte a me numerose persone affette da malattia neoplastica, inizialmente per un aiuto nutrizionale che poi, grazie alla formazione offerta dalla scuola è diventato qualcosa di più efficace. La casistica che ho potuto così raccogliere è diventata piuttosto ampia soprattutto per quanto riguardava la gestione degli effetti collaterali della chemioterapia e i tempi di sopravvivenza liberi da malattia. Perciò inizialmente questo studio voleva essere molto più ampio, ma mi sono trovata davanti a difficoltà nella stesura del lavoro legate alla eterogeneità delle diverse patologie, al diverso stadio a cui arrivavano alla mia attenzione, alla personalizzazione dei trattamenti, alla irregolarità con cui alcuni soggetti seguivano i consigli e all’exitus di un paio di persone. Più di una volta, davanti ad un insuccesso, sono stata sul punto di non accettare la sfida per una perdita di fiducia nei confronti di questo tipo di approccio e di cambiare completamente l’argomento di questa tesi.

Alla fine, tuttavia, ho orientato questo studio ad una patologia unica, confortata dal fatto di poter seguire adeguatamente l’andamento della terapia anche se limitatamente a 2 soggetti. La raccolta dei dati ed il follow up è attualmente di 1 anno e mezzo e mi ha permesso di capire alcuni aspetti importanti, sia della malattia che dell’approccio alla persona che non può essere standardizzato, sia per motivi caratteriali che, purtroppo, economici. Mi sono anche resa conto che il supporto naturopatico permette di creare un rapporto di fiducia che va oltre il rapporto professionale.

Quello che ho imparato, dopo 18 anni di lavoro in strutture gestite dalla medicina ufficiale, è che l’approccio non convenzionale si preoccupa realmente della persona e non delle statistiche a cui questa può prendere parte, che ogni persona è diversa e va trattata come tale e non come un semplice “caso clinico” o “numero”.

Fonti

  1. Abrams K.Le alghe per la salute. 1999. Tecniche Nuove pag 35
  2. Aso Y, Azaka H, Kotake T et al . Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double-blind trial. 1995 Eur.Urol. 27:104-109
  3. Assouline S, Miller W.H. 2006. High-dose vitamin C therapy: renewed hope or false promise? CMAJ Vol 174(7) : 956-957
  4. Calvino N, Levine S - Vitamin C anc cancer: storm of controversy - www.positivehealth.com
  5. Cameron E, Campbell A. The orthomolecular treatment of cancer. Clinical trial of high-dose ascorbic acid supplements in advanced human cancer. Chem Biol Interact 1974. 9:285-315
  6. Cameron E, Campbell A., Jack T. The orthomolecular treatment of cancer. Reticulum cell sarcoma: double complete regression induced by high-dose ascorbic acid therapy. Chem Biol Interact 1975. II:3685-3689
  7. Cameron, E. and Pauling, L. Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer. 1976. PNAS USA, 73:3685-3689,
  8. Cameron, E. and Pauling, L. The orthomolecular treatment of cancer: Reevaluation of prolongation of survival times in terminal human cancer. 1978 PNAS USA, 75:4538-4542.
  9. Casciari, J.J., Riordan NH, Schmidt, T.L., Meng, X.L., Jackson JA, Riordan HD. Cytotoxicity of ascorbate, lipoic acid, and other antioxidants in hollow fibre in vitro tumours. British J Cancer. 2001, 84(11), 1544-1550
  10. Chen Q., Espey MG, Krishna MC., Mitchell JB., Corpe CP., Buettner GR., Shacter E, Levine M. Pharmacologic ascorbic acid concentrations selectively kill cancer cells: Action as a pro-drug to deliver hydrogen peroxide to tissues PNAS USA. 2005 September 20; 102(38): 13604-13609)
  11. Chinery R, Brockman JA, Peeler MO, Shyr Y, , Beauchamp RD, Coffey RJ. Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: a p53-independent induction of p21 via C/EPB. 1997. Nat.Med. 3: 1233-1241
  12. Conklin KA. Dietary antioxidants during cancer chemotherapy: impact on chemoterapeutic effectiveness and development of side effects. 2000. Nutr.Cancer 37(1): 1-18.
  13. Creagan ET, Moertel CG, O'Fallon JR, Schutt AJ, O'Connell MJ, Rubin J, Frytak S Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer. A controlled trial. : NEJM 1979 Sep 27;301(13):687-90
  14. D’Andrea GM. Use of antioxidant during chemotherapy and radiotherapy should be avoided. 2005 CA Cancer J.Clin; Vol.55: 319-321.
  15. Drisko JA, Chapman J, Hunter VJ. The use of antioxidant therapies during chemotherapy. 2003. Gynecologic Oncology 88: 434-439
  16. Enstrom J.E., et al. Vitamin C intake and mortality among a sample of the United States population. Epidemiology, Vol. 3, No. 3, May 1992, pp. 194-202
  17. Gilloteaux J., Jamison J. M., Arnold D., Ervin E., Eckroat L., Docherty J. J., Neal D., Summers J. L.. Cancer Cell Necrosis by Autoschizis: Synergism of Antitumor Activity of Vitamin C: Vitamin K3 on Human Bladder Carcinoma T24 Cells. 1998. Scanning. 20, 564-575
  18. Gitte JJ et al. 2000. Consumption of Aphanizomenon Flos Aquae has rapid effect on the circulation and function of immune cells in humans. Journal of American Nutraceutical Association (JANA) Vol.2 (3): 50-58.
  19. Gonzales MJ, Miranda-Massari JR, Mora EM, Guzman A, Riordan NH, Riordan HD, Casciari JJ, Jackson JA, Roman-Franco A. 2005. Orthomolecular oncology review: ascorbic acid and cancer 25 years later. Integrative cancer therapies Vol. 4(1): 32-44.
  20. Gotos et al. 1998. Analysis of TH1 and TH2 cytokine production by peripheral blood mononuclear cells as a parameter of immunological dysfunction in advanced cancer patients, Cancer Immunology and Immunotherapy 48: 435.
  21. Hatch G.E. Asthma, inhaled oxidants, and dietary antioxidants. American Journal of Clinical Nutrition, Vol. 61, No. 3, March 1995, pp. 625S-30S
  22. Hobbs C. 1995. Medicinal mushrooms. An exploration of tradition, healing and culture. Botanica Press, Santa Cruz, CA.
  23. Ikekawa T. 1995. Enokitake, Flammulina velutipes: antitumor activity of extracts and polysaccharides. Food Review International 11, 203-206.
  24. Ito H, Shimura H, Itoh M, Kaurode M. 1997. Antitumor effects of a new polysaccharide-protein complex (ATOM) prepared from Agaricus blazei (Iwade strain 101) Himematsuke and its mechanisms in tumor-bearing mice. Anticancer research Jan.-Feb. 17(IA) 277-284.
  25. Jacobs EJ et al. 2001. Vitamin C and vitamin E supplement use and colorectal cancer mortality in a large American Cancer Society cohort. Cancer Epidemiology Biomarker Prev. 10: 17-23.
  26. Jamison JM, Gilloteaux J, Taper HS, Summers JL. Evaluation of the in vitro and in vivo antitumor activities of vitamin C and K-3 combinations against human prostate cancer. J Nutr 2001 Jan;131(1):158S-160S
  27. Jong SC, Birmingham JM. 1992. Medicinal benefits of the mushroom Ganoderma. Advances in Applied Microbiology 37, 101-134
  28. Jong SC, Donovick R. 1989. Antitumoral and antiviral substances from fungi. Advances in Applied Microbiology 34, 183-262
  29. Kazue et al. 2000. Natural cytotoxic activity of peripheral blood lymphocytes in cancer incidents: an 11 year follow up study of a general population. The Lancet Vol.356: 1795-1799.
  30. Kidd P. Th1/Th2 balance: the hypotesis, its limitations, and implications for health and disease.2003 Alternative Medicine Review Vol. 8(3): 223-246
  31. Kristal AR et al. 1999. Vitamin and mineral supplement use is associated with reduced risk of prostate cancer. Cancer Epidemiology Biomarker Prev. 9(7): 647-652.
  32. Kurashiga S, Akuzawa Y, EudoF. 1997. Effects of Lentinus edodes, Grifola frondosa and Pleurotus ostreatus administration on cancer outbreaks and activities of macrophages and lymphocytes in mice treated with a carcinogen N-butyl-N-butamolinitroso-amine. Immunopharmacology and Immunotoxicology 19, 175-183.
  33. Lahitova N. et al. 1994. Antimutagenic properties of fresh water blue-green algae. Folia Microbiologica (Praha) 39 (4): 301-303
  34. Lamm DL, Riggs DR, Shriver JS et al. 1994. Megadose vitamins in bladder cancer: a double blind clinical trial. Journal of Urology 151(1): 21-26.
  35. Lamson DW, Bringnall MS. 2000. Antioxidant and cancer therapy II: quick reference guide. Alternative Medicine Review. 5(2)
  36. Lindequist U., Niedermeyer THJ, Jülich WD. The pharmacological potential of mushrooms. 2005. eCAM; 2(3): 285-299
  37. Liu GT. 1999. Recent advances in research of pharmacology and clinical applications of Ganoderma species in China. International Journal of Medicinal Mushrooms 1, 63-67.
  38. Levine GN. et al. Ascorbic acid reverses endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation, Vol. 93, No. 6, March 15, 1996, pp. 1107-13
  39. Lunec J. B. The determination of dehydroascorbic acid and ascorbic acid in the serum and synovial fluid of patients with rheumatoid arthritis. Free Radical Research Communications, Vol. 1, No. 1, 1985, pp. 31-9
  40. Luo Y, Chen X, O’Donnell A. Role of TH1 and TH2 cytokines in BCG-induced IFN-γ production: cytokine promotion and simulation of BCG effect. Cytokine 2003. 21:17-26
  41. Manoukian R. et al 1998. Effect of the blue-green algae Aphanizomenon Flos Aquae on human natural killer cells. Ed Phytoceuticals, IBC Library series pag 233-241
  42. Mezzetti A. et al. Systemic oxidative stress and its relationship with age and illness. Journal of the American Geriatrics Society, Vol. 44, No.7, July 1996, pp. 823-27
  43. Mizuno T. 1995. Mushrooms: the versatile fungus - food and medicinal properties. Food Reviews International (special issue) 2: 1-235.
  44. Mizuno T. 1999. Bioactive substances in Hericium erinaceus and its medicinal utilisation. International Journal of Medicinal Mushrooms 1, 105-119.
  45. Mizuno T. 2000. Development of an antitumor biological response modifier from Phellinus linteus. Review. International Journal of Medicinal Mushrooms 2, 21-33.
  46. Moertel CG, Fleming TR, Creagan ET, J Rubin, MJ O'Connell, and MM Ames. High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison. New England Journal of Medicine 312:137-141, 1985
  47. Morgan et al. 2004. The contribution of cytotoxic chemotherapy to 5-year survival in adult malignancies. Clin.Oncol. 16: 549-560.
  48. Padayatty SJ, Sun H, Wang Y, Riordan HD, Hewitt SM, Katz A, Wesley RA, Levine M. Vitamin C pharmacokinetics: implications for oral and intravenous use. 2004 Ann.Intern.Med. Vol.140: 533-537
  49. Parker-Pope T. Cancer and vitamins: patient urged to avoid supplements during treatment. 2005 Wall Street Journal. Sept.20; D1
  50. Pecere T., Gazzola MV, Mucignat C, Parolin C, Dalla Vecchia F, Cavaggioni A, Basso G, Diaspro A, Salvato B, Carli M, Palù G. 2000. Aloe-emodin is a new type of anticancer agent with selective activity against neuroectodermal tumors. Cancer research Vol. 60: 2800-2804
  51. Podmore ID, Griffiths HR, Kerbert KE. 1998. Vitamin C exhibits pro-oxidant properties. Nature 392: 559.
  52. Powell M. 2004. The use of ganoderma lucidum (Reishi) in the management of histamine-mediated allergic responses. Nutritional Practitioner Magazine Oct 2004: 26-30.
  53. Prasad KN, Edward-Prasad J. Vitamin E and cancer prevention: recent advances and future potentials. 1992. J.Am.Coll.Nutr. 11: 487-500
  54. Prasad KN, Kumar A, Kochupillai V, Cole WC. High doses of multiple antioxidant vitamins: essential ingredients in improving the efficacy of standard cancer therapy. 1999. J.Am.Coll. Nutr. 18: 13-25.
  55. Sliva D. Ganoderma lucidum (Reishi) in cancer treatment. 2003. Integrative Cancer Therapies. Vol. 2(4): 358-364.
  56. Sperandio S. De Belle I., Bredesen DE. An alternative, nonapoptotic form of programmed cell death. 2000. PNAS 97(26): 14376-14381.
  57. Tomoda H. et al. Possible prevention of post-angioplasty restenosis by ascorbic acid. American Journal of Cardiology, Vol. 78, No. 11, December 1, 1996, pp. 1284-86
  58. Teicher BA, Schwartz JL, Golden SA, Ara G, Northey D. In vivo modulation of several anticancer agents by -carotene. 1994. Cancer Chemother.Pharmacol. 34: 235-241
  59. Wang SY, Hsu ML, Hsu HC, Tzeng SS, Lee SS, Shiao MS, HO CR. 1997. The antitumor effect of Ganoderma lucidum is mediated by citokines released from activated macrophages and T-lymphocytes. International Journal of Cancer 70(6): 669-705.
  60. Wasser SP, Weis AL. 1999a. Medicinal properties of substances occurring in higher Basidiomycetes: current perspectives (Review). International Journal of Medicinal Mushrooms 1, 31-62.
  61. Wasser SP, Weis AL. 1999b. General description of the most important medicinal higher Basidiomycetes mushrooms. International Journal of Medicinal Mushrooms 1, 351-370.
  62. Ying J.Z., Mao X.L., Ma Q.M., Zong Y.C, Wen H.A. 1987. Icons of Medicinal Fungi from China. Science Press Beijing.
  63. Zhao JD, Zhang XQ, 1994. Resources and taxonomy of Lingzhi (Ganoderma) in China. From program and extracts of the 1994 International Symposium in Ganoderma research. Beijing, BeijingMedical University.
  64. Zhuang C, Mizuno T. 1999. Biological responses from Grifola frondosa - Maitake . International Journal of Medicinal Mushrooms 1, 317-324.
  65. http://www.cancer.org - sito American Cancer Society;
  66. http://www.nlm.nih.org/medlineplus/bladdercancer.html
  67. http://www.icnet.uk/labs/med_mush/med_mush.html
  68. Jensen GS et al. 2001. Blue green algae as an immuno-henancer and biomodulator. JANA 3(4): 24-30
  69. Jacobs EJ., Henion AK, Briggs PJ et al. Vitamin C and vitamin E supplement use and bladder cancer in a large cohort of US men and women. 2002 Am.J.Epidemiol. 156:1002-1010
  70. Padayatty SJ, Riordan HD, Hewitt SM, Katz A, Hoffer LJ, Levine M. Intravenously administered vitamin C as cancer therapy: three cases. CMAJ • March 28, 2006; 174 (7). doi:10.1503/cmaj.050346
  71. De Magistris R, Fittipaldi A, Reale P, Della Peruta A, D’Addio F, Nardella M, Caruso F, Letizia M. 2003. Alimentazione e malattie cronico-degenerative. La Medicina Biologica Gennaio-Marzo 2003: 28-35.